# Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CA

> **NCT00394615** · NA · TERMINATED · sponsor: **Stanford University** · enrollment: 15 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **PROCEDURE:** Metabolic Imaging

## Key facts

- **NCT ID:** NCT00394615
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-10
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 15 (ESTIMATED)
- **Why stopped:** Protocol approval expired
- **Last updated:** 2010-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00394615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00394615, "Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CA". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00394615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*